GB806584A - Novel pyrimidine derivatives and a process for the manufacture thereof - Google Patents

Novel pyrimidine derivatives and a process for the manufacture thereof

Info

Publication number
GB806584A
GB806584A GB14630/57A GB1463057A GB806584A GB 806584 A GB806584 A GB 806584A GB 14630/57 A GB14630/57 A GB 14630/57A GB 1463057 A GB1463057 A GB 1463057A GB 806584 A GB806584 A GB 806584A
Authority
GB
United Kingdom
Prior art keywords
fluoro
ether
uracil
ethyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14630/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB806584A publication Critical patent/GB806584A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises 5-fluoro-uracil, 5-fluoro-thiouracil, their 6-carboxy derivatives, salts thereof, also 2-ethers of 5-fluoro-uracil and 5 - fluoro - thiouracil, their 6 - alkoxy - carbonyl derivatives and their salts, together with a process for their preparation by reacting an alkali metal fluoro-acetate with an alkylating agent, condensing the alkyl fluoro-acetate with an alkyl formate or dialkyl oxalate in the presence of an alkali metal condensing agent, reacting the resulting alkali metal enolate of an alkyl fluoro-malonaldehydate or dialkyl fluoro-oxalacetate with a 2-ether of pseudo-urea or isothiourea, and, where the product is a 2-ether of 5-fluoro-uracil or thiouracil, hydrolysing the 2-ether group to a hydroxyl group with acid or, where the product is a 2-ether of a 5-fluoro-orotic acid ester of thio-orotic acid ester, hydrolysing the 6-ester group with acid or alkali and the 2-ether group with acid and, if desired, decarboxylating the resulting 6-carboxy-5-fluoro-uracil by heating, or alternatively, where the product is a 2-ether of 5-fluoro-thiouracil or a 6-alkoxycarbonylthiouracil, either hydrolysing the ester group if present and splitting the ether group with anhydrous hydrogen halide (or for benzyl ethers with aluminium bromide) and if desired, oxidizing the resulting 5-fluorothiouracil or 5-fluoro-thio-orotic acid with hydrogen peroxide to give 5-fluoro-uracil or 5-fluoro-orotic acid and, if desired, decarboxylating the latter, or replacing the 4-hydroxyl group by halogen using a phosphorus pentahalide, reacting the resulting 2-ether of a 5-fluoro-4-halogeno - 2 - mercaptopyrimidine or 6 - alkoxy carbonyl derivative thereof with ammonia, hydrolysing the ether and ester groups of the resulting 2-ether of 2-thio-4-amino-5-fluoro-pyrimidine or 6-alkoxycarbonyl derivative thereof, treating the product with nitrous acid to give 5-fluorouracil or 5-fluoro-orotic acid, and if desired decarboxylating the latter. In an example: sodium fluoro-acetate and diethyl sulphate are refluxed giving ethyl fluoroacetate, which is reacted with (a) ethyl formate, or (b) diethyl oxalate in the presence of potassium ethoxide yielding the potassium enolate of ethyl fluoro-malonaldehydrate (I), or of diethyl fluoro-oxalacetate (II) respectively; (I) O-methylpseudourea hydrochloride and sodium methoxide are refluxed in methanol giving the 2-methyl ether of 5-fluorouracil; similarly (I) and S-methyl-isothiouronium sulphate give 2-methylmercapto-5-fluoro-uracil (the S-ethyl and S-benzyl ethers are also described); (II) with S-ethyl-isothiouronium bromide or S-methyl-isothiouronium sulphate give the S-ethyl and S-methyl ethers of 5-fluoro-thio-orotic ethyl ester (or methyl ester using sodium methoxide) respectively; 5-fluoro-uracil 2-methyl ether with HCl gives 5-fluoro-uracil, also obtained from 5-fluoro-uracil S-methyl and S-ethyl ether, while hydrolysis of the S-ethyl ether of 5-fluoro-thio-orotic acid ethyl ester gives 5-fluoro-oritic acid monohydrate; the S-methyl ether of 5-fluoro-thiouracil is heated with HI in acetic acid-acetic anhydride, giving 5-fluoro-thiouracil (also prepared from the S-benzyl ether and AlBr3 in toluene) which on oxidation with alkaline H2O2 gives 5-fluoro-uracil; the S-ethyl ether of 5-fluoro-thiouracil is reacted with PCl5, the resulting 2-ethylmercapto-4-chloro-5-fluoropyrimidine autoclaved with liquid ammonia and the 2-ethylmercapto-4-amino-5-fluoropyrimidine obtained refluxed with HBr yielding 5-fluoro-cytosine, which with nitrous acid gives 5-fluoro-uracil; 5-fluoro-orotic acid is decarboxylated by heating above its m. pt. or in diphenyl-diphenyl oxide to give 5-fluoro-uracil.
GB14630/57A 1956-05-08 1957-05-08 Novel pyrimidine derivatives and a process for the manufacture thereof Expired GB806584A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US806584XA 1956-05-08 1956-05-08

Publications (1)

Publication Number Publication Date
GB806584A true GB806584A (en) 1958-12-31

Family

ID=22158784

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14630/57A Expired GB806584A (en) 1956-05-08 1957-05-08 Novel pyrimidine derivatives and a process for the manufacture thereof

Country Status (1)

Country Link
GB (1) GB806584A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS545985A (en) * 1977-06-17 1979-01-17 Asahi Glass Co Ltd Preparation of 5-fluorouracil
CN105153041A (en) * 2015-10-20 2015-12-16 浙江先锋科技股份有限公司 5-fluctyosine preparation method suitable for industrial production
CN106632080A (en) * 2016-08-25 2017-05-10 宿迁市万和泰化工有限公司 Flucytosine manufacturing process

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS545985A (en) * 1977-06-17 1979-01-17 Asahi Glass Co Ltd Preparation of 5-fluorouracil
JPS5426559B2 (en) * 1977-06-17 1979-09-04
CN105153041A (en) * 2015-10-20 2015-12-16 浙江先锋科技股份有限公司 5-fluctyosine preparation method suitable for industrial production
CN106632080A (en) * 2016-08-25 2017-05-10 宿迁市万和泰化工有限公司 Flucytosine manufacturing process

Similar Documents

Publication Publication Date Title
GB806584A (en) Novel pyrimidine derivatives and a process for the manufacture thereof
IE780285L (en) PROCESS FOR THE PREPARATION OF d,l -5-METHYLTETRAHYDROFOLIC¹ACID
KR840001530A (en) Dispersant Composition
GB1157199A (en) Process for the preparation of Zearalane
GB1038346A (en) Processes for preparing 2-alkyl-cyclopentane derivatives, and the derivatives thus prepared
GB741667A (en) New pyrimidine derivatives
GB1472967A (en) Process for the manufacture of 2-methyl-5,6-dihydropyran-
GB800777A (en) A novel pyrimidine derivative and a process for the manufacture thereof
GB785069A (en) New heterocyclic compounds
GB1212054A (en) d,l-NORZEALANE AND THE PREPARATION THEREOF
GB896104A (en) Steroid compounds and their preparation
GB1382469A (en) Cyclohexanepentol derivatives and process for preparing the same
GB948631A (en) Cyclopentanophenanthrene derivatives and process for their production
JPS5612327A (en) Manufacture of 3*33dimethylarylalcohol
GB982197A (en) Yohimb-17-ene derivatives
GB632395A (en) Improvements in or relating to 6-substituted thiouracil compounds and process of preparing the same
GB585299A (en) Improvements in or relating to the manufacture of aldol
GB813927A (en) ª‡-benzyl-ª†-methyl-n-trityl-l-(+)-glutamate and alkyl homologs thereof
GB761091A (en) Process for the production of thiobarbiturates
GB1312193A (en) Process for the manufacture of 6,6-alkylenedioxyheptan-2-ones
GB790842A (en) Substituted cyclopentenes and methods of preparing same
GB983341A (en) Substituted succinic acid esters
GB865310A (en) A process for the productionof 2-cis-ª‰-ionylidene acetic acid
GB876607A (en) Alkali metal salts and alkaline earth metal salts of n-isonicotinylhydrazine n-glucuronide and a process for their production
GB1475867A (en) Process for the manufacture of ketals